Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|Dizocilpine||MK-801||Dizocilpine (MK-801) is an uncompetitive antagonist against the N-Methyl-D-aspartate ionotropic glutamate receptor (PMID: 3529096), and demonstrates anti-proliferative effects against cancer cells (PMID: 16230611).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Unknown unknown||melanoma||not applicable||Dizocilpine||Preclinical - Cell culture||Actionable||In a preclinical study, the NMDA antagonist, Dizocilpine (MK-801), demonstrated effectiveness against melanoma cells in culture (PMID: 24240127).||24240127|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|